A digital therapeutic component to optimize induction of buprenorphine-containing products

Abstract

A system comprises data processing hardware and memory hardware in communication with the data processing hardware, the memory hardware storing instructions that when executed on the data processing hardware cause the data processing hardware to perform operations comprising executing a prescription digital therapeutic configured to treat symptoms associated with opioid use disorder in a patient, wherein executing the prescription digital therapeutic comprises receiving a plurality of inputs associated with the patient from one or more of (i) first sensors associated directly with the patient and (ii) second sensors associated with a patient electronic device, wherein the plurality of inputs represent a level of opioid withdrawal associated with the patient, weighting the plurality of inputs associated with the patient to provide a plurality of weighted inputs, determining a recommended dosage of a buprenorphine-containing product for the patient based on the plurality of weighted inputs, and instructing an administration unit to administer the recommended dosage of the buprenorphine-containing product to the patient.

Description

[0001] Cross References to Related Applications [0002] This US patent application claims priority under 35 U.S.C. §119(e) to US Provisional Application 62 / 779,705, filed December 14, 2018. The disclosure of the earlier application is considered part of the disclosure of the present application and is hereby incorporated by reference in its entirety. technical field [0003] The present disclosure relates to digital therapeutics, and more particularly to systems and methods for using digital therapeutics to improve adherence to and induction of medications, such as buprenorphine-containing products. Background technique [0004] The information provided in this section is for the purpose of generally presenting the context of this application. To the extent described in this section, the work of the presently named inventors and aspects of the presently named inventors that, at the time of filing, may not be consistent with the description of the prior art are neither expr...

AI Technical Summary

Problems solved by technology

For those patients seeking OUD treatment, lack of drug attachment and high attrition rates limit effectiveness

Images